Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Infect Dis ; 216(3): 375-381, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28119486

ABSTRACT

Uropathogenic Escherichia coli (UPEC), the primary causative agents of urinary tract infections, colonize and invade the epithelial cells of the bladder urothelium. Infection of immature urothelial cells can result in the formation of persistent intracellular reservoirs that are refractory to antibiotic treatments. Previously, we defined a novel therapeutic strategy that used the bladder cell exfoliant chitosan to deplete UPEC reservoirs. However, although a single treatment of chitosan followed by ciprofloxacin administration had a marked effect on reducing UPEC titers within the bladder, this treatment failed to prevent relapsing bacteriuria. We show here that repeated use of chitosan in conjunction with the antibiotic ciprofloxacin completely eradicates UPEC from the urinary tract and prevents the development of relapsing bouts of bacteriuria. In addition, microscopy revealed rapid restoration of bladder integrity following chitosan treatment, indicating that chitosan can be used to effectively combat recalcitrant bladder infections without causing lasting harm to the urothelium.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteriuria/drug therapy , Chitosan/therapeutic use , Ciprofloxacin/therapeutic use , Escherichia coli Infections/drug therapy , Uropathogenic Escherichia coli/drug effects , Animals , Female , Humans , Mice , Mice, Inbred C57BL , Recurrence , Urinary Bladder/pathology , Urothelium/pathology
SELECTION OF CITATIONS
SEARCH DETAIL